Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults (PSC25)
This study is ongoing, but not recruiting participants.
Sponsor:
Protein Sciences Corporation
Information provided by (Responsible Party):
Protein Sciences Corporation
ClinicalTrials.gov Identifier:
NCT01612000
First received: May 7, 2012
Last updated: December 4, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |